| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C0005574> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C0006137> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C0013227> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33886709_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Instituto de Tecnologia em Fármacos, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.\', \'Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Fernandes_Daniela_Rangel_Affonso> <https://research.tib.eu/covid-19/entity/Gadelha_Carlos_Augusto_Grabois> <https://research.tib.eu/covid-19/entity/Maldonado_Jose_Manuel_Santos_de_Varge>
?:doi	S0102-311X202100040500210.1590/0102-311X00254720
?:doi	<https://research.tib.eu/covid-19/entity/S0102-311X202100040500210.1590/0102-311X00254720>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Cadernos de saude publica
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33886709>
?:pmid	<https://research.tib.eu/covid-19/entity/33886709>
?:pmid	33886709
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.568
?:rankingScore_hIndex	66
?:title	[Vulnerabilities of Brazil\'s domestic pharmaceutical and biotech industry in the context of the COVID-19 pandemic].
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33886709>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33886709>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all